U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma

MedGen UID:
90818
•Concept ID:
C0334630
•
Neoplastic Process
Synonyms: Classical Hodgkin lymphoma, nodular sclerosis, grade 2; Grade 2 Nodular Sclerosis Classical Hodgkin Lymphoma; Grade 2 Nodular Sclerosis Hodgkin Lymphoma; Grade 2 Nodular Sclerosis Hodgkin's Lymphoma; Grade II Nodular Sclerosis Hodgkin's Lymphoma; Hodgkin lymphoma, nodular sclerosis, grade 2; Hodgkin's disease, nodular sclerosis, lymphocyte depletion; Hodgkin's disease, nodular sclerosis, lymphocytic depletion; Hodgkin's disease, nodular sclerosis, syncytial variant
SNOMED CT: Hodgkin's disease, nodular sclerosis, lymphocyte depletion (43985008); Classical Hodgkin lymphoma, nodular sclerosis, grade 2 (43985008); Hodgkin lymphoma, nodular sclerosis, grade 2 (43985008); Hodgkin's disease, nodular sclerosis, lymphocytic depletion (43985008); Hodgkin's disease, nodular sclerosis, syncytial variant (43985008)

Definition

Nodular sclerosis Hodgkin lymphoma in which at least 25% of the tumor nodules contain increased numbers of Reed-Sternberg cells. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGrade 2 Nodular Sclerosis Classic Hodgkin Lymphoma

Professional guidelines

PubMed

Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Massano D, Carraro E, Mussolin L, Buffardi S, Barat V, Zama D, Muggeo P, Vendemini F, Sau A, Moleti ML, Verzegnassi F, D'Amico S, Casini T, Garaventa A, Schiavello E, Cellini M, Vinti L, Farruggia P, Perruccio K, Cesaro S, De Santis R, Marinoni M, D'Alba I, Mura RM, Burnelli R, Mascarin M, Pillon M
Pediatr Blood Cancer 2022 Oct;69(10):e29801. Epub 2022 Jun 2 doi: 10.1002/pbc.29801. PMID: 35656841

Recent clinical studies

Etiology

Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Massano D, Carraro E, Mussolin L, Buffardi S, Barat V, Zama D, Muggeo P, Vendemini F, Sau A, Moleti ML, Verzegnassi F, D'Amico S, Casini T, Garaventa A, Schiavello E, Cellini M, Vinti L, Farruggia P, Perruccio K, Cesaro S, De Santis R, Marinoni M, D'Alba I, Mura RM, Burnelli R, Mascarin M, Pillon M
Pediatr Blood Cancer 2022 Oct;69(10):e29801. Epub 2022 Jun 2 doi: 10.1002/pbc.29801. PMID: 35656841
Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
Slack GW, Ferry JA, Hasserjian RP, Sohani AR, Longtine JA, Harris NL, Zukerberg LR
Leuk Lymphoma 2009 Jun;50(6):937-43. doi: 10.1080/10428190902930488. PMID: 19455461
Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
Asano N, Oshiro A, Matsuo K, Kagami Y, Ishida F, Suzuki R, Kinoshita T, Shimoyama Y, Tamaru J, Yoshino T, Kitamura K, Fukutani H, Morishima Y, Nakamura S
J Clin Oncol 2006 Oct 1;24(28):4626-33. Epub 2006 Sep 5 doi: 10.1200/JCO.2006.06.5342. PMID: 16954517
The pattern of lymphoma in east Malaysian patients as experienced in the University Hospital, Kuala Lumpur.
Chai SP, Peh SC, Kim LH, Lim MY, Gudum HR
Malays J Pathol 1999 Jun;21(1):45-50. PMID: 10879278
Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Pappa VI, Norton AJ, Gupta RK, Wilson AM, Rohatiner AZ, Lister TA
Ann Oncol 1995 Jul;6(6):559-65. doi: 10.1093/oxfordjournals.annonc.a059244. PMID: 8573534

Diagnosis

Composite Classic Hodgkin Lymphoma and Follicular Lymphoma: A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature.
Huang Y, Hu S, Larson DP, Shi M, He R, Dave BJ, Greiner TC, Fu K, McPhail ED, Ketterling RP, Medeiros LJ, Yuan J
Am J Surg Pathol 2022 Jun 1;46(6):793-800. Epub 2022 Jan 24 doi: 10.1097/PAS.0000000000001828. PMID: 35067515
GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B, Alhyari M, Venkataraman G, Karner K, Inamdar KV, Menon MP
Appl Immunohistochem Mol Morphol 2019 Mar;27(3):180-184. doi: 10.1097/PAI.0000000000000581. PMID: 28877074
Nodular sclerosis classical Hodgkin lymphoma grade 2: A diagnostic challenge to the cytopathologists.
Sharma S, Dey P, Mitra S, Rajwanshi A, Nijhawan R, Srinivasan R, Gupta N, Das A
Cancer Cytopathol 2017 Feb;125(2):104-113. Epub 2016 Nov 21 doi: 10.1002/cncy.21799. PMID: 27870472
Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
Slack GW, Ferry JA, Hasserjian RP, Sohani AR, Longtine JA, Harris NL, Zukerberg LR
Leuk Lymphoma 2009 Jun;50(6):937-43. doi: 10.1080/10428190902930488. PMID: 19455461
MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.
Hsi ED, Sup SJ, Alemany C, Tso E, Skacel M, Elson P, Alonso MA, Pohlman B
Am J Clin Pathol 2006 May;125(5):776-82. doi: 10.1309/98KL-HRDA-M5CM-DHE2. PMID: 16707382

Therapy

Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Massano D, Carraro E, Mussolin L, Buffardi S, Barat V, Zama D, Muggeo P, Vendemini F, Sau A, Moleti ML, Verzegnassi F, D'Amico S, Casini T, Garaventa A, Schiavello E, Cellini M, Vinti L, Farruggia P, Perruccio K, Cesaro S, De Santis R, Marinoni M, D'Alba I, Mura RM, Burnelli R, Mascarin M, Pillon M
Pediatr Blood Cancer 2022 Oct;69(10):e29801. Epub 2022 Jun 2 doi: 10.1002/pbc.29801. PMID: 35656841
Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma.
Harris MA, Radford JA, Deakin DP, James RD, Swindell R, Cowan RA
Clin Oncol (R Coll Radiol) 2004 Feb;16(1):53-7. doi: 10.1016/j.clon.2003.08.007. PMID: 14768756
Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Pappa VI, Norton AJ, Gupta RK, Wilson AM, Rohatiner AZ, Lister TA
Ann Oncol 1995 Jul;6(6):559-65. doi: 10.1093/oxfordjournals.annonc.a059244. PMID: 8573534

Prognosis

GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B, Alhyari M, Venkataraman G, Karner K, Inamdar KV, Menon MP
Appl Immunohistochem Mol Morphol 2019 Mar;27(3):180-184. doi: 10.1097/PAI.0000000000000581. PMID: 28877074
Nodular sclerosis classical Hodgkin lymphoma grade 2: A diagnostic challenge to the cytopathologists.
Sharma S, Dey P, Mitra S, Rajwanshi A, Nijhawan R, Srinivasan R, Gupta N, Das A
Cancer Cytopathol 2017 Feb;125(2):104-113. Epub 2016 Nov 21 doi: 10.1002/cncy.21799. PMID: 27870472
MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.
Hsi ED, Sup SJ, Alemany C, Tso E, Skacel M, Elson P, Alonso MA, Pohlman B
Am J Clin Pathol 2006 May;125(5):776-82. doi: 10.1309/98KL-HRDA-M5CM-DHE2. PMID: 16707382
Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors.
von Wasielewski R, Seth S, Franklin J, Fischer R, Hübner K, Hansmann ML, Diehl V, Georgii A
Blood 2000 Feb 15;95(4):1207-13. PMID: 10666192
Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Pappa VI, Norton AJ, Gupta RK, Wilson AM, Rohatiner AZ, Lister TA
Ann Oncol 1995 Jul;6(6):559-65. doi: 10.1093/oxfordjournals.annonc.a059244. PMID: 8573534

Clinical prediction guides

Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Massano D, Carraro E, Mussolin L, Buffardi S, Barat V, Zama D, Muggeo P, Vendemini F, Sau A, Moleti ML, Verzegnassi F, D'Amico S, Casini T, Garaventa A, Schiavello E, Cellini M, Vinti L, Farruggia P, Perruccio K, Cesaro S, De Santis R, Marinoni M, D'Alba I, Mura RM, Burnelli R, Mascarin M, Pillon M
Pediatr Blood Cancer 2022 Oct;69(10):e29801. Epub 2022 Jun 2 doi: 10.1002/pbc.29801. PMID: 35656841
GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B, Alhyari M, Venkataraman G, Karner K, Inamdar KV, Menon MP
Appl Immunohistochem Mol Morphol 2019 Mar;27(3):180-184. doi: 10.1097/PAI.0000000000000581. PMID: 28877074
MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.
Hsi ED, Sup SJ, Alemany C, Tso E, Skacel M, Elson P, Alonso MA, Pohlman B
Am J Clin Pathol 2006 May;125(5):776-82. doi: 10.1309/98KL-HRDA-M5CM-DHE2. PMID: 16707382
Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H, Wahed A, Rassidakis GZ, Medeiros LJ
Mod Pathol 2002 Nov;15(11):1221-6. doi: 10.1097/01.MP.0000036386.87517.AA. PMID: 12429802
Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Pappa VI, Norton AJ, Gupta RK, Wilson AM, Rohatiner AZ, Lister TA
Ann Oncol 1995 Jul;6(6):559-65. doi: 10.1093/oxfordjournals.annonc.a059244. PMID: 8573534

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...